Literature DB >> 6094676

Relation of titers of antibodies to CMV in blood donors to the transmission of cytomegalovirus infection.

J S Beneke, G E Tegtmeier, H J Alter, R B Luetkemeyer, R Solomon, W L Bayer.   

Abstract

Titers of antibody to cytomegalovirus (CMV) of 529 persons whose blood had been supplied to 51 selected patients who underwent open-heart surgery were determined by indirect hemagglutination (IHA) and IgM-specific indirect immunofluorescence (IFA). Twenty-eight patients showed evidence of active CMV infection after transfusion (seroconversion or a fourfold rise in titer by IHA), whereas 23 showed no serological change. Patients with active CMV infections had received, on average, a greater number of blood units (12.9 vs. 7.9), of which more were seropositive (6.9 vs. 3.5), than did patients who showed no serological change. Those seropositive units of blood that had been transfused into the group that showed evidence of active infection, however, had a lower geometric mean titer than did those transfused into the group that showed no serological change (1:654 vs. 1:1,360). Seven (1.3%) of the 529 blood donors had CMV-specific IgM titers (by IFA) of greater than or equal to 1:16; each of the seven recipients of their blood subsequently showed evidence of active CMV infection. This study suggests that donor blood with high IHA titers may prevent transmission of CMV infection, whereas blood from donors with IgM antibody to CMV may transmit CMV.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6094676     DOI: 10.1093/infdis/150.6.883

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

Review 1.  Prevention of Transfusion-Transmitted Cytomegalovirus Infections: Which is the Optimal Strategy?

Authors:  Malte Ziemann; Holger Hennig
Journal:  Transfus Med Hemother       Date:  2013-12-19       Impact factor: 3.747

2.  Detection of antibody to cytomegalovirus-induced early antigens and comparison with four serologic assays and presence of viruria in blood donors.

Authors:  E B Lentz; N L Dock; C A McMahon; S R Fiesthumel; C B Arnold; H V Lamberson
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948

3.  Cytomegalovirus (CMV) mononucleosis syndrome.

Authors:  A A Bhave; M Chandy; T J John; A Sudarsanam; S Christopher; D Dennison
Journal:  Indian J Pediatr       Date:  1994 Sep-Oct       Impact factor: 1.967

4.  Rapid detection of cytomegalovirus in clinical specimens by using biotinylated DNA probes and analysis of cross-reactivity with herpes simplex virus.

Authors:  N S Lurain; K D Thompson; S K Farrand
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

5.  Immunoglobulin M to cytomegalovirus in primary and reactivation infections in renal transplant recipients.

Authors:  S Chou; D Y Kim; K M Scott; D L Sewell
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

Review 6.  Acquisition of cytomegalovirus infection: an update.

Authors:  B A Forbes
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

7.  Cytomegalovirus DNA detection in sera from patients with active cytomegalovirus infections.

Authors:  M Brytting; W Xu; B Wahren; V A Sundqvist
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

8.  Transfusion-related cytomegalovirus infection among very low birth weight infants in an endemic area.

Authors:  Ai-Rhan Ellen Kim; Yeon Kyung Lee; Kyung Ah Kim; Young Kyu Chu; Byung Yoon Baik; Eun Soon Kim; Sung Cheol Yun; Ki Soo Kim; Soo Young Pi
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.